Dermapharm
DMP.F
#4241
Rank
NZ$4.72 B
Marketcap
NZ$95.34
Share price
-5.24%
Change (1 day)
51.32%
Change (1 year)

Financial Statements

Thumbnail Dermapharm Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2025

Financial Statement 2025

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2024

Financial Statement 2024

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2023

Financial Statement 2023

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2022

Financial Statement 2022

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2021

Financial Statement 2021

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2020

Financial Statement 2020

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2019

Financial Statement 2019

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2018

Financial Statement 2018

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2017

Financial Statement 2017

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2017

Financial Statement 2017

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2016

Financial Statement 2016

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2016

Financial Statement 2016

Language: German

View Financial Statement